SLC1A2 and amyotrophic lateral sclerosis: Increase in excitatory synaptic drive as a contributor to ALS is supported by overall loss of excitatory amino acid transporter 2 (EAAT2) in the motor cortex and spinal cord of ALS patients, which could lead to glutamate excitotoxicity (Rothstein et al. 1995).